Saturday, September 13, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Accord Healthcare launches Agomelatine Accord 25 mg

IPN by IPN
13 February 2019
in Product News
0

Accord Healthcare have recently announced the launch of Agomelatine Accord 25 mg which is available in a pack size of 28 Film Coated Tablets.

This medicine is indicated for the treatment of major depressive episodes in adults.

Please refer to the Summary of Product Characteristics (SPC) available at www.hpra.ie or for Healthcare Professionals at www.accord-healthcare.ie for further information.

For further information please contact Accord in Cork on 021-461 9040 or visit www.accord-healthcare.ie

Previous Post

Beeline Healthcare launches New Vegetarian Multivitamins

Next Post

Falsified Medicines Directive, what you need to know

Next Post

Falsified Medicines Directive, what you need to know

Leave a Reply

Your email address will not be published. Required fields are marked *

McCabes Pharmacy launches nationwide flu vaccination service as research shows parents hit hard by flu

McCabes Pharmacy launches nationwide flu vaccination service as research shows parents hit hard by flu

11 September 2025
Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

4 September 2025
EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

4 September 2025

RECOMMENDED NEWS

Feeling the Chill: Cough, Cold and Flu

Feeling the Chill: Cough, Cold and Flu

3 years ago
IQVIA Top 100 Pharmacy Products

IQVIA Top 100 Pharmacy Products

1 year ago
Coaching

Lead with Coaching – Empowering Sustainable Growth and Workforce Wellbeing, Written by Rachel Dungan, MPSI MCC ACTC

1 year ago
Cardiovascular Disease on Men’s Health

Cardiovascular Disease on Men’s Health

2 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN